WO2013066403A1 - Botanical antimicrobial composition - Google Patents

Botanical antimicrobial composition Download PDF

Info

Publication number
WO2013066403A1
WO2013066403A1 PCT/US2012/037135 US2012037135W WO2013066403A1 WO 2013066403 A1 WO2013066403 A1 WO 2013066403A1 US 2012037135 W US2012037135 W US 2012037135W WO 2013066403 A1 WO2013066403 A1 WO 2013066403A1
Authority
WO
WIPO (PCT)
Prior art keywords
oil
extract
benzyl alcohol
alcohol
botanical
Prior art date
Application number
PCT/US2012/037135
Other languages
English (en)
French (fr)
Inventor
Shanta M. Modak
Santoshkumar DONGRE
Lauserpina Caraos
Nayana Baiju
Hari Krishnan Ramachandran
Original Assignee
The Trustees Of Columbia University In The City Of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/412,464 external-priority patent/US20130230609A1/en
Application filed by The Trustees Of Columbia University In The City Of New York filed Critical The Trustees Of Columbia University In The City Of New York
Priority to CN201280064657.3A priority Critical patent/CN104039338A/zh
Priority to IN4034CHN2014 priority patent/IN2014CN04034A/en
Priority to EP12846062.3A priority patent/EP2775847A4/en
Priority to CA2890395A priority patent/CA2890395C/en
Priority to AU2012333187A priority patent/AU2012333187A1/en
Priority to JP2014539926A priority patent/JP2015501330A/ja
Publication of WO2013066403A1 publication Critical patent/WO2013066403A1/en
Priority to US14/267,606 priority patent/US9968101B2/en
Priority to US15/928,735 priority patent/US20180206505A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08—Magnoliopsida [dicotyledons]
    • A01N65/22—Lamiaceae or Labiatae [Mint family], e.g. thyme, rosemary, skullcap, selfheal, lavender, perilla, pennyroyal, peppermint or spearmint
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/40—Liliopsida [monocotyledons]
    • A01N65/44—Poaceae or Gramineae [Grass family], e.g. bamboo, lemon grass or citronella grass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/382—Vegetable products, e.g. soya meal, wood flour, sawdust
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions

Definitions

  • compositions comprising antimicrobially effective combinations of benzyl alcohol, essential oils and botanical extracts (including plant extracts and fruit extracts).
  • Essential oils are volatile oils obtained from plant or animal sources and are composed of complex mixtures of several constituents, such as monoterpenes and sesquiterpene hydrocarbons, monoterpene and sesquiterpene alcohols, esters, ethers, aldehydes, ketones, oxides and the like. These essential oils and their isolated constituents are frequently utilized as fragrance and flavor agents, and have been widely used in folk medicine for wound healing properties.
  • Essential oils of eucalyptus have been found to "possess central and peripheral analgesic effects as well as neutrophil-dependent and independent anti-inflammatory activities" (Silva et al., 2003, J. Ethnopharmacol. 89(2-3);277-283), and similar activity has been observed in essential oils from Lavendula angustifolia Mill. (Hajhashemi et al., 2003, J. Ethnopharniacol. 89(i):67 ⁇ 71). Essential oils have been demonstrated to exhibit antibacterial (Bezic et al., 2003, Phytother. Res.
  • Virucidal activity of essential oils has also been observed, including direct virucidal effects against Herpes simplex viruses types 1 and 2 (Garcia et al., Phytother. Res. 17(9): 1073- 1075; Minami et al., 2003, Microbial Immunol. 47(a):681-684; Schuhmacher et al, 2003, Phytomedicine 10:504- 510).
  • compositions comprising a quaternary ammonium compound and an essential oil (or active component thereof).
  • compositions comprising an essential oil (or component thereof) where zinc salts are added to inhibit irritation associated with essential oils.
  • Examples of such patent applications include United States Patent Application Publication No. 20040102429 by Modak et al., published May 27, 2004 and United States Patent Application Publication No. 20050238602 by Modak et al., published October 27, 2005, now U.S. Patent No. 7,435,429.
  • a non-toxic mold inhibitor which may be a plant extract such as an essential oil.
  • United States Patent No. 5,310,546 by Douglas, issued May 10, 1994 relates to a mouth rinse preparation comprising hydrogen peroxide, zinc chloride, sodium citrate, sodium lauryl sulfate, citric acid and ethanol and optionally an essential oil which is a denaturing agent.
  • BiON offers several skin care products comprising citric acid, botanicals, and other agents for topical use (San Diego, CA, US).
  • Johnson et al. (U.S. Pat. No. 6,319,958 and US20020165130) relates to the use of sesquiterpenoids to promote uptake of exogenous antimicrobial compounds.
  • a related article discloses the use of sesquiterpenoids, such as nerolidol, farnesol, bisabolol and apritone, in enhancing bacterial permeability and susceptibility to exogenous antimicrobial compounds, suggesting that sesquiterpenoids have a non-specific and general effect (Brehm-Stecher et al, 2003, Antimicrobial Agents and Chemotherapy, 47(10):3357-3360).
  • nerolidol, farnesol, bisabolol and apritone enhanced the susceptibility of S. aureus to the antibiotics erythromycin, gentamicin, vancomycin, ciproflaxin, clindamycin, and tetracycline.
  • United States Patent No. 6,753,305 by Raso and Caselli, issued June 22, 2004, relates to a hard surface disinfectant comprising up to 20 percent of cinnamon oil or a component thereof, 0.01-5 percent of an organic acid, and optionally an additional essential oil.
  • topical ointments have been used. These ointments have incorporated silver sulfadiazine (U.S. Patent No. 3,761 ,590, incorporated herein by reference) or various antibiotics. A topical ointment for burns has also been reported which contains a combination of silver salts and norfloxocin, a quinoline antibiotic, or its salts (U.S. Patent No. 4,404,197, incorporated hereby by reference). In the case where the antibiotic is silver norfloxocin, U.S. Patent No. 4,404,197 reports a synergistic enhancement of activity. U.S. Patent No. 5,374,432 relates to topical anti -infective ointments containing an antibiotic, silver salt, and sterile carrier. These compositions were found to not only provide improved antimicrobial efficacy, but also reduced incidence of microbial resistance.
  • U.S. Patent No. 6,987,133 relates to a topical preparation containing silver sulfadiazine dispersed or solubilized in a cream or lotion base matrix which can be sprayed directly on the burn wound.
  • European Patent No. EP0653214 relates to a topical antibacterial preparation containing silver sulfadiazine and collagen for the treatment of infected hands and for the advancement of their healing. There is a continuing desire for an antimicrobial or wound healing composition that are non- irritating, safe, and effective for repeated use in various professional and non-professional settings. 3. SUMMARY
  • compositions comprising antimicrobially effective low concentrations of benzyl alcohol, one or more essential oil and one or more botanical extract, in certain embodiments, compositions are provided having antimicrobial active agents that are substantially or essentially entirely derived from natural sources, thereby allowing the user to avoid harsh and/or toxic chemicals. This may be particularly advantageous in products for use by or on children or pets or for use in households or other environments occupied by children or animals.
  • an antimicrobial composition comprising benzyl alcohol (from about 0.1 %(w/w) to about 10% (w/w)), one or more essential oil such as but not limited to lemongrass oil, cinnamon oil, thyme oil, galanga oil, orange oil, pomegranate oil, curry leaf oil and combinations thereof (from about 0.02%(w/w) to about 1.0% (w/w)), and one or more botanical extract such as wasabi extract, grapefruit seed extract, honey suckle extract, cedarwood extract, pomegranate extract, Echinacea extract, aspen bark extract, willow bark extract , citrus extract, Brahmi extract and combinations there of (from about 0.1 %(w/w)- 1.0% (w/w)).
  • essential oil such as but not limited to lemongrass oil, cinnamon oil, thyme oil, galanga oil, orange oil, pomegranate oil, curry leaf oil and combinations thereof (from about 0.02%(w/w) to about 1.0% (w/w)
  • botanical extract such as wasabi
  • Optional ingredients include one or more sesquiterpenoid such as farnesol, nerolidol, bisabolol, apritone, citral and combinations thereof (from about 0.03%(w/w) to about 2% (w/w)), one or more plant derived alcohol (from about 5%(w/w) to about 20% (w/w)), one or more natural organic acid such as a fruit acid, benzoic acid, salicylic acid and combinations thereof (from about 0.02%(w/w) to about 2.0%o(w/w)), and vegetable glycerin.
  • sesquiterpenoid such as farnesol, nerolidol, bisabolol, apritone, citral and combinations thereof (from about 0.03%(w/w) to about 2% (w/w))
  • one or more plant derived alcohol from about 5%(w/w) to about 20% (w/w)
  • one or more natural organic acid such as a fruit acid, benzoic acid, salicylic acid
  • an antimicrobial composition comprising:
  • composition from about 0.1%(w/w) to about 4% (w/w) sesquiterpenoid, wherein the composition does not comprise an alkanediol.
  • an antimicrobial composition comprising:
  • (c) from about 0.5%(w/w) to about 10% (w/w) botanical extract selected from the group consisting of wasabi extract, honeysuckle extract, cedar wood extract, aspen bark extract, willow bark extract, tobacco extract, and combinations thereof.
  • an antimicrobial composition comprising:
  • composition does not comprise an alkanediol.
  • an antimicrobial composition comprising
  • composition further comprises from about 0.2%(w/w) to about 2.0% (w/w) of one or more botanical selected from the group consisting of wasabi extract, grapefruit extract, citrus extract, honeysuckle extract, aloe gel, and aloe leaf juice.
  • the composition further comprises from about 0.1%(w/w) to about 0.5% (w/w) zinc oxide.
  • the composition further comprises from about 0.2%>(w/w) to about 0.5% > sodium benzoate.
  • the composition further comprises from about 0.1%(w/w) to about 1.0 % (w/w) pentanediol.
  • the composition further comprises grapefruit seed or another citrus extract, for example, at a concentration from about 0.3%(w/w) to about 1.0% (w/w).
  • the composition further comprises one or more of Vitamin E and/or Vitamin C, for example with each being at a concentration from about 0.02%(w/w) to about 0.2% (w/w).
  • the composition further comprises a sesquiterpenoid or a mixture of sesquiterpenoids, for example at a concentration from about 0.3%(w/w) to about 2.0% (w/w).
  • the composition does not comprise an antibiotic or antiseptic agent which is a biguanide, a chlorinated phenol, or a quaternary ammonium compound.
  • the composition does not comprise phenylethanol.
  • the composition does not comprise phenoxyethanol.
  • the composition does not comprise polymixin, miconazole, fluconazole, itriconazole, or keoconazole.
  • the composition does not comprise neomycin.
  • the composition does not comprise bacitracin.
  • the composition does not comprise povidone iodine or other iodine-containing compounds.
  • an antimicrobial composition comprising
  • composition further comprises from about 0.2%(w/w) to about 2.0% (w/w) of one or more botanical selected from the group consisting of wasabi extract, grapefruit extract, citrus extract, honeysuckle extract, aloe gel, and aloe leaf juice.
  • the composition further comprises from about 0.5%(w/w) to about 3.0%o (w/w) pentylene glycol.
  • the composition further comprises from about 0.5%(w/w) to about 2.0% (w/w) of a cationic surfactant.
  • the composition does not comprise an antibiotic or antiseptic agent which is a biguanide, a chlorinated phenol, or a quaternary ammonium compound.
  • the composition does not comprise phenylethanol. In certain subsets of this embodiment, the composition does not comprise polymixin, miconazole, fluconazole, itriconazole, or keoconazole. In certain subsets of this embodiment, the composition does not comprise neomycin. In certain subsets of this embodiment, the composition does not comprise bacitracin. In certain subsets of this embodiment, the composition does not comprise povidone iodine or other iodine-containing compounds.
  • an antimicrobial composition comprising
  • the composition does not comprise an antibiotic or antiseptic agent which is a biguanide, a chlorinated phenol, or a quaternary ammonium compound.
  • the composition does not comprise phenoxyethanol.
  • the composition does not comprise polymixin, miconazole, fluconazole, itriconazole, or keoconazole.
  • the composition does not comprise neomycin. In certain subsets of this embodiment, the composition does not comprise bacitracin. In certain subsets of this embodiment, the composition does not comprise povidone iodine or other iodine-containing compounds. In certain non-limiting embodiments, a disinfectant is provided comprising
  • a wound-healing composition comprising
  • a surface disinfectant comprising:
  • aliphatic alcohol for example, but not limited to, a mixture of aliphatic alcohols, for example mixtures of ethanol and propanol or butanol, e.g., SDA 3C or SDA 40B
  • aliphatic alcohol for example, but not limited to, a mixture of aliphatic alcohols, for example mixtures of ethanol and propanol or butanol, e.g., SDA 3C or SDA 40B
  • a surface disinfectant comprising:
  • a cleaning composition comprising from about l%(w/w) to about 5% (w/w) lemongrass oil, from about 0.1%(w/w) to about 1 % (w/w) pine oil, and from about 5%(w/w) to about 20% (w/w) citric acid.
  • the compositions may be utilized in personal care products such as soaps, scrubs, cosmetics, topical creams and lotions, wound care products, burn wound cream, decubitous ulcer cream (with antiinflammatory botanicals and the use of silver sulfadiazene as an anti-microbial agent), rapidly acting skin disinfectants, disinfecting wipes, and veterinary products, such as antimicrobial lotion for mastitis, teat dip, and therapeutic ointments.
  • personal care products such as soaps, scrubs, cosmetics, topical creams and lotions, wound care products, burn wound cream, decubitous ulcer cream (with antiinflammatory botanicals and the use of silver sulfadiazene as an anti-microbial agent), rapidly acting skin disinfectants, disinfecting wipes, and veterinary products, such as antimicrobial lotion for mastitis, teat dip, and therapeutic ointments.
  • the compositions of the application may be used in concentrations from about 1% to about 10%o in personal care products or topical creams.
  • the compositions may be utilized in
  • compositions disclosed herein comprise benzyl alcohol, at a concentration (percent weight/weight, "% w/w") from about 0.05%(w/w) to about 60 % w/w, or from aboput 0.5%(w/w) to about 50%(w/w), or from about 0.5%(w/w) to about 50%(w/w); or from about 0.5%(w/w) to about 2.0%(w/w), or from about 0.1 %(w/w) to about 2.0% (w/w), or from about 0.1%(w/w) to about 0.5%(w/w), or from about 0.5%(w/w) to about 5%(w/w), or from about 5.0%(w/w) to about 20% (w r /w), including but not limited to about 0.05%(w/w , 0.1 %(w/w) , 0.5%(w/w),1 .0%(w/w), 2.0%(w/w), 3.0%(w/w), 4.0%(w/w), 5.0%(w
  • compositions disclosed herein comprise benzyl alcohol, at a concentration of between about 0.1 and about 0.5 % w/w; or between about 0.1 and about 0.45 % w/w; or between about 0.1 and about 0.4 % w/w; or between about 0.1 and about 0.35 % w/w; or between about 0.1 and about 0.3 % w/w; or between about 0.1 and about 0.25 % w/w; or between about 0.1 and about 0.2 % w/w; or between about 0.1 and about 0.15 % w/w.
  • Benzyl alcohol for use in the compositions disclosed herein may be produced synthetically or may be obtained from one or more natural plant (botanical) source.
  • Essential oils are volatile oils obtained from plant or animal sources, or their synthetic equivalents, and are composed of complex mixtures of several constituents such as monoterpenes and sesquiterpene hydrocarbons, monoterpene and sesquiterpene alcohols, esters, ethers, aldehydes, ketones, oxides and the like.
  • EOs include, but are not limited to, cinnamo oil (e.g., cinnamon leaf oil or cinnamon bark oil), basil oil, bergamot oil, clary sage oil, ylang-ylang oil, neroli oil, sandalwood oil, frankincense oil, ginger oil, peppermint oil, lavender oil, jasmine absolute, geranium oil bourbon, spearmint oil, clove oil, patchouli oil, rosemary oil, rosewood oil, sandalwood oil, tea tree oil, vanilla oil, lemongrass oil, oregano oil, thymol, galangal oil, cedar wood oil, balsam oils, tangerine oil, Hinoki oil, Hiba oil, ginko oil, eucalyptus oil, lemon oil, orange oil, sweet orange oil, pomegranate seed oil, pomegranate oil, manuka oil, citronella oil, curry leaf oil, and calendula oil.
  • cinnamo oil e.g., cinnamon leaf oil or
  • ICs Individual constituents of essential oils may be isolated from the oil (natural) or may be entirely or partially chemically synthetic, and include, but are not limited to, thyme, oregano, curcumin, 1-citronellol, a-amylcinnamaldehyde, lyral, geraniol, faniesol, hydroxycitronellal, isoeugenol, eugenol, camphor, eucalyptol, linalool, citral, thymol, limonene and menthol.
  • Further examples of ICs include sesquiterpenoid compounds, which may be the active compounds in the essential oils.
  • Sesquiterpenoid compounds containing 15 carbons, are formed bios>Tithetically from three 5 -carbon isoprene units.
  • Sesquiterpenoid compounds include, but are not limited to, farnesol, nerolidol, bisabolol, apritone, chamazulene, santalol, zingiberol, carotol, and caryophyllen.
  • an IC is selected from the (non-limiting) group consisting of camphor, curcumin, alpha-pinene, constituents of cinnamon leaf oil such as, cinnamaldehyde, cinnamyl acetic ester, cinnamic acid, ethyl cinnamate, methyl chavicol, linalool, beta-caryophyllene, and eugenol; constituents of lemongrass oil such as d-limonene, geranyl acetate, nerol, geraniol, citral, and/or myrcene; constituents of citronella oil such as geraniol, citronellol, citronellal, geranyl acetate, limonene, methyl isou
  • the EO is selected from one or more EO from the group consisting of cinnamon oil (CO) (bark or leaf), lemongrass oil (LGO), and basil oil (BO), all of which have little to no fragrance, or nonfragrant oils such as pomegranate seed oil (PSO).
  • CO cinnamon oil
  • LGO lemongrass oil
  • BO basil oil
  • PSO pomegranate seed oil
  • Calendula contains high amounts of flavonoids, plant-based antioxidants that protect the body against cell-damaging free radicals. It appears to have anti-inflammatory, antiviral, and antibacterial effects. Animal studies show that calendula accelerates wound healing, possibly by increasing blood flow to the wounded area and by helping the body produce collagen proteins, which are used to heal skin and connective tissue. 4.3 BOTANICAL EXTRACTS
  • Botanical extracts include plant, herbal, and fruit extracts, w r hich are not "essential oils” as noted above.
  • the botanical extracts utilized herein include but are not limited to wasabi, honeysuckle, cedar wood, aspen bark, willow bark, Brahmi (Bacopa monnieri) extract, citrus extract Camellia sinensis (green tea), grapes, pomegranate, Echinacea, Centella Asiatica, Elderflower, Irish moss, Mallow, soap bark, Yucca, Clary sage, oregano, thyme, curcumin compounds, resveratrol (polyphenols compound from grape, berries, etc.) vetivert and mixtures thereof.
  • the botanical utilized to obtain the botanical extract may be obtained from any of the plant parts including the leaves, pulp, seeds, or stems, fruit and fruit seeds, as well as the whole plant.
  • Herbal extracts can be, for example, standardized extracts that are dispersible and/or soluble in aqueous medium.
  • herbal extracts include, without limitation, extracts of chamomile, rosemary, aloe, nettle, Centella asiatica, ginkgo biloba, betula, and witch hazel. Such extracts may be delivered in a carrier such as water, propylene glycol, hydroalcohol, glycerine, or butylene glycol. Additional extracts with nutritional quality can be used, including, without limitation, green tea, white tea, grape skin, grape seed, resveratrol grapefruit, grapefruit seed, grapefruit peel, citrus fruits (other than grapefruit extract) bilberry, blueberry, Ginkgo biloba, soy isoflavones, soy extract, fermented soy protein, black cohosh, St.
  • Botanical extracts can be obtained from, for example, Active Organics (Lewisville, Tex.), New Age Botanicals (Garland, Tex.), Triarco Industries (Wayne, N.J.), and Aloecorp (Broomfield, Colo.).
  • nonfragrant botanicals include pomegranate seed oil (PSO), mixtures of edible plant extract Kefiprotect (KP), and tetrahydrocurcuminoid (THC).
  • Turmeric and curcuminoids have been documented to have anti inflammatory, antioxidant and wound healing properties,
  • the following curcuminoids can be used in topical creams, tetrahydrocurcumin, tetrahydrodemethoxycurcumin, tetrahydrobisdemethoxycurcumin, and mixtures thereof.
  • Additional examples of botanical extracts include coconut derived phospholipid (Arlasik phospholipid PTM), natural blends of fatty acids which mimic those found in the stratum corneum, mixture of fatty acids with pigments such as carotenes, carotenoids or phytosterols that are known to facilitate repair to damaged skin, and the like.
  • useful botanical extracts include avocado, which contains the sterol sitosterol; carrot, which contains beta carotene; sesame oil which contains a mixture of saturated and unsaturated fatty acids, and brazil nut oil. Because of its broad distribution of fatty acids, extracts such as brazil nut oil, can outperform single fatty acids with respect to incorporation into the lipid lamellar structures.
  • Brazil nut oil (BNO) originates from the harvested fruit from the South American rain forest tree: Bertholletia excelsa.
  • Botanical extracts also include flavonoids and terpenoids.
  • the flavonoids contemplated by the present subject matter include, but are not limited to, turin, quercetin, hesperidin, and naringin.
  • Terpenoids contemplated by the present subject matter include, but are not limited to, monoterpenes, sesquiterpenes, and diterpenes.
  • the botanical extract is selected, from one or more extract selected from the group consisting of grapefruit seed extract (GSE), pomegranate seed oil (PSO), citrus fruit extract, or mixtures of edible plant extract Kefiprotect (KP), coconut derived phospholipid (Arlasik phospholipid PTM), and tetrahydrocurcuminoid (THC).
  • GSE grapefruit seed extract
  • PSO pomegranate seed oil
  • KP vegetable plant extract
  • KP coconut derived phospholipid
  • THC tetrahydrocurcuminoid
  • compositions disclosed herein comprise one or more sesquiterpenoid selected from the group consisting of farnesol, nerolidol, bisabolol, apritone, citral and combinations thereof.
  • sesquiterpenoid selected from the group consisting of farnesol, nerolidol, bisabolol, apritone, citral and combinations thereof.
  • bifunctional alcohols which may be used according to the present subject matter are alkanediols.
  • alkanediols include, but are not limited to, propanediol, butanediol, dodecanediol, decanediol, nonanediol, octanediol, heptanediol, hexanediol, and pentanediol.
  • the alkanediols have a carbon backbone of between 3 and 25 carbon atoms, including but not limited to 1,9 Nonanediol, 1,2-Decanediol, 1,10-Decanediol, 1,11-Undecanediol, 1 ,2-Dodecanediol, 1 ,12 Dodecanediol, Cyclododecanediol, 1,13-Tridecanediol, 1 ,2- Tetradecanediol, 1 , 14-Tetradecanediol, 1 , 15-Pentadecanediol, 1 , 16-Hexadecanediol, 1 ,17-Heptadecanediol, 1 ,18-OctadecanedioI, 1,19-Nonadecanediol, 1,20- Eicosanediol, 1,21-H
  • an alkanediol is obtained from a natural product. In certain embodiments an alkanediol is chemically synthesized.
  • compositions of the present subject matter may include one or more solvent, including but not limited to solvent(s) selected from the group consisting of water, alcohols, plant derived alcohols, glycols, glycerol, glycerine, octoxyglycerin, diglycerol, propylene glycol, dipropylene glycol, and vegetable oils.
  • solvent(s) selected from the group consisting of water, alcohols, plant derived alcohols, glycols, glycerol, glycerine, octoxyglycerin, diglycerol, propylene glycol, dipropylene glycol, and vegetable oils.
  • non-alkanediol alcohols for solubilization are aliphatic alcohols having between about 1 and 8 carbon atoms such as methanol, ethanol, n-propanol, isopropyl alcohol, 2-methyl-2 propanol, hexanol, or combinations thereof.
  • Aromatic alcohols for example, but not by way of limitation, phenoxyethanol, benzyl alcohol, 1 -phenoxy-2-propanol, and/or phenethyl alcohol, may also optionally be used in combination with aliphatic alcohols.
  • Aromatic alcohols for example, but not by way of limitation, include phenoxyethanol, benzyl alcohol, l-phenoxy-2 -propanol, and/or phenethyl alcohol, for example at a concentration of between about 0.5 and 5 % (weight/weight) may also optionally be used in combination with aliphatic alcohols.
  • a further solvent which optionally may be comprised in a composition of the application is isopropyl myristate.
  • Additional aliphatic alcohols include ethanol, denatured alcohol (SDA 40B and SDA 3C) and isopropanol.
  • Compositions comprising combinations of benzyl alcohol, botanicals, and 1 ,3 propanediol and its derivatives such as 2-methyl-l-nitro 1 ,3-propanediol (Diol) or 2-Hydroxymethyl 2-nitro 1,3-propanediol (Triol), may further contain cosolvents such as glycerin, octoxyglycerin, alcohol, glycols, butanediol, and phenoxy ethanol.
  • cosolvents such as glycerin, octoxyglycerin, alcohol, glycols, butanediol, and phenoxy ethanol.
  • the solvent is benzyl alcohol, glycerin, or a combination thereof
  • the solvents are used at concentrations ranging from about 0.001 % to about 90% (w/w), or from about 1 % to about 85% (w/w), or from about 10% to about 70% (w/w), or from about 30% to about 65% (w/w). In alternative embodiments, the concentration ranges range from about 5% to about 90% (w/w), preferably from about 30% to about 90%. (w/w), and more preferably from about 40%) to about 80% (w/w).
  • the solvent is a natural product, for example, benzyl alcohol derived from the Cassia plant.
  • the solvent is benzyl alcohol or its derivatives, e.g., hydroxy! benzyl alcohol, nitro benzyl alcohol, or other derivatives.
  • Benzyl alcohol concentrations ranging from about 0.5% to about 10% (w/w), preferably from about 0.5% to about 5% (w/w), more preferably from about 0.5% to about 4% (w/w), have been found to exhibit antimicrobial efficacy with certain botanical organic acids, and in particular fruit acids.
  • Alternative embodiments use from about 1.0% to about 5.0% (w/w), or from about 1 % to about 3% (w/w) benzyl alcohol.
  • Use of other botanicals and synthetic antimicrobials along with benzyl alcohol and these acids further enhances the activity as discussed in further detail below.
  • Natural organic acids such as fruit acids, which may be used according to the application include but are not limited to fruit acid, citric acid, glycolic acid, lactic acid, malic acid, tartaric acid, benzoic acid, salicylic acid, and acetic acid.
  • the fruit acid is Multifruit BSC (Arch Chemicals), which is a mixture of lactic, citric, tartaric, glycolic, and malic acid extracted from plants.
  • the fruit acid is lactic acid.
  • a fruit acid for use in the application may be obtained from its natural source or may be chemically synthesized.
  • organic acids which may be used in compositions disclosed herein include but are not limited to benzoic acid and its derivatives including salt forms, for example, a benzyl benzoate, paraamino benzoic acid, nitro benzoic acid, hydroxy! benzoic acid, flurobenzoic acid, and benzyl salicylate.
  • Fruit acids may be used according to the application to assist in the controlled release of the silver compound.
  • Non-limiting examples of fruit acids include but are not limited to citric acid, glycolic acid, lactic acid, malic acid, tartaric acid and acetic acid.
  • the fruit acid is Multifont BSC (Arch Chemicals), which is a mixture of lactic, citric, tartaric, glycolic, and malic acid extracted from plants.
  • a fruit acid for use in the compositions of the present subject matter may be obtained from its natural source or may be chemically synthesized.
  • the fruit acid is lactic acid or citric acid.
  • concentrations of fruit acids ranges from about 0% to about 70% (w/w), or from about 5% to about 70% (w/w), or from about 5% to about 20% (w/w), or from about 10% to about 20% (w/w).
  • the concentrations range from about 0% to about 20% (w/w), or from about 0% to about 40% (w/w), or from about 0.1% to about 20% (w/w), or from about 0.2% to about 4% (w/w), or from about 0.5% to about 4% (w/w), or from about 2% to about 4% (w/w).
  • the concentrations of natural organic acid present in a composition for use range from about 0.2% to about 2% (w/w), or from about 0.2 to about 1% (w/w).
  • the natural organic acids are present in a composition for use at concentrations ranging from between about 0.01% to about 5%> (w/w), or from about 0.01% to about 4% (w/w), or from about 0.01% to about 3% (w/w), or from about 0.01% to about 2% (w/w), or from about 0.01% to about 1% (w/w), or from about 0.02% to about 5% (w/w), or from about 0.02% to about 4% (w/w), or from about 0.02% to about 3% (w/w), or from about 0.02% to about 2% (w/w), or from about 0.02% to about 1% (w/w), or from about 0.05% to about 2.0% (w/w), or from about 0.1% to about 2.0% (w/w).
  • personal care product compositions comprising benzyl alcohol and one or more essential oil and/or one or more botanical extract, for example a plant or fruit extract.
  • the pH of personal care products is between about 3.0 and 6.0.
  • Non-limiting examples of personal care products which may utilize the compositions of the present subject matter include bar soap, liquid soap (e.g., hand soap), hand sanitizer (including rinse off and leave-on alcohol based and aqueous- based hand disinfectants), preoperative skin disinfectant, cleansing wipes, disinfecting wipes, body wash, acne treatment products, antifungal diaper rash cream, antifungal skin cream, shampoo, conditioner, cosmetics (including but not limited to liquid or powder foundation, liquid or solid eyeliner, mascara, cream eye shadow, tinted powder, "pancake” type powder to be used dry or moistened, etc.) deodorant, antimicrobial creams, body lotion, hand cream, topical cream, aftershave lotion, skin toner, mouth wash, toothpaste, sunscreen !otion, and baby products such as, but not limited to, cleansing wipes, baby shampoo, baby soap, and diaper cream.
  • liquid soap e.g., hand soap
  • hand sanitizer including rinse off and leave-on alcohol based and aqueous-
  • wound care items such as, but not limited to, wound healing ointments, creams, and lotions, wound coverings, burn wound cream, bandages, tape, and steri-strips, and medical articles such as medical gowns, caps, face masks, and shoe-covers, surgical drops, etc.
  • Additional products inc!ude are not limited to oral products such, as mouth rinse, toothpaste, and dental floss coatings, veterinary and pet care products, preservative compositions, and surface disinfectants including solutions, sprays or wipes.
  • Personal care compositions provided herein may further comprise one or (preferably) more than one component selected from the group consisting of emollients, stabilizing agents, thickening agents, humectants, anti-inflammatory agents, antimicrobial agents, neutralizing agents, surfactants, water, silicone polymers, alcohols, and hydrogels, as well as additional components as may be known in the art.
  • emollients emollients
  • stabilizing agents e.g., thickening agents, humectants, anti-inflammatory agents, antimicrobial agents, neutralizing agents, surfactants, water, silicone polymers, alcohols, and hydrogels
  • humectants e.g., humectants
  • anti-inflammatory agents e.g., antimicrobial agents, neutralizing agents, surfactants, water, silicone polymers, alcohols, and hydrogels
  • neutralizing agents e.g., surfactants, water, silicone polymers, alcohols, and hydrogels
  • a personal care product may comprise an emollient, for example PEG 20 almond glycerides, Probutyl DB-10, Glucam P-20, Glucam E-10, Glucam P-10, Glucam E-20, Glucam P ⁇ 20 distearate, glycerin, propylene glycol, octoxyglycerin, cetyl acetate, acetylated lanolin alcohol (e.g.
  • an emollient for example PEG 20 almond glycerides, Probutyl DB-10, Glucam P-20, Glucam E-10, Glucam P-10, Glucam E-20, Glucam P ⁇ 20 distearate, glycerin, propylene glycol, octoxyglycerin, cetyl acetate, acetylated lanolin alcohol (e.g.
  • cetyl ether e.g., PPG- 10
  • myristyril ether e.g., PPG-3
  • hydroxylated milk glycerides e.g., Cremeral HMG
  • polyquaternium compounds e.g., U-care compounds
  • copolymers of dimethyl dialyl ammonium chloride and acrylic acid e.g., Merquat
  • dipropylene glycol methyl ethers e.g., Dowanol DPM, Dow Corning
  • polypropylene glycol ethers e.g., Ucon 50-HB-600, Union Carbide
  • silicon polymers e.g., Ucon 50-HB-600, Union Carbide
  • emollients may include hydrocarbon-based emollients such as petrolatum or mineral oil, fatty ester-based emollients, such as methyl, isopropyl and butyl esters of fatty acids such as isopropyl palmitate, isopropyl myristate, isopropyl isostearate, isostearyl isostearate, diisopropyl sebacate, and propylene dipelargonate, 2-ethylhexyl isononoate, 2-ethylhexyI stearate, Ci 2 - C] 6 fatty alcohol lactates such as cetyl lactate and lauryl lactate, isopropyl lanolate, 2- ethylhexyl salicylate, cetyl myristate, oleyl myristate, oleyl stearate, oleyl oleate, hexyl laurate, and isohexyl laurate
  • a personal care product may comprise a stabilizing agent such as an antioxidant, for example but not limited to vitamin C (ascorbic acid) and/or vitamin E (tocopherol), and/or a surfactant, for example but not limited to incromide or silicone-based surfactants (Masil SF- 19, BASF).
  • a stabilizing agent such as an antioxidant, for example but not limited to vitamin C (ascorbic acid) and/or vitamin E (tocopherol)
  • a surfactant for example but not limited to incromide or silicone-based surfactants (Masil SF- 19, BASF).
  • a personal care product may comprise a thickening and/or gelling agent such as stearyl alcohol, cationic hydroxy ethyl cellulose (Ucare; JR30), hydroxy propyl methyl cellulose, hydroxy propyl cellulose (Klucel), chitosan pyrrolidone carboxylate (Kytamer), behenyl alcohol, zinc stearate, emulsifying waxes, including but not limited to Incroquat and Polawax, an addition polymer of acrylic acid, a resin such as Carbopol® ETDTM 2020, guar gum, acacia, acrylates/steareth-20 methacrylate copolymer, agar, algin, alginic acid, ammonium acrylate co-polymers, ammonium alginate, ammonium chloride, ammonium sulfate, amylopectin, attapulgite, bentonite, C9-15 alcohols
  • the gelling agents used in vehicles may be natural gelling agents such as natural gums, starches, pectins, agar and gelatin. Often, the gelling agents are based on polysaccharides or proteins Examples include but are not limited to guar gum, Xanthum gum, Alginic acid (E400), sodium alginate (E401 ), potassium alginate (E402), ammonium alginate (E403 alkanediol, may further comprise a humectant, such as, for example, glycerin, 1-2-propyIene glycol, dipropylene glycol, polyethylene glycol, 1,3-butylene glycol, or 1,2,6-hexanetriol.
  • a humectant such as, for example, glycerin, 1-2-propyIene glycol, dipropylene glycol, polyethylene glycol, 1,3-butylene glycol, or 1,2,6-hexanetriol.
  • one or more additional antimicrobial agent may be comprised, for example, where such antimicrobial agent may be selected from the group consisting of silver salts, iodophors, iodine, benzoic acid, dihydroacetic acid, propionic acid, sorbic acid, methyl paraben, ethyl paraben, propyl paraben, butyl paraben, cetrimide, benzalkonium chloride, dequalinium chloride, chlorhexidine, chloroeresol, chlorxylenol, benzyl alcohol, bronopol, chlorbutanol, phenoxyethanol, phenylethyl alcohol, 2,4-dichlorobenzyl alcohol, thiomersal, clindamycin, erythromycin, benzoyl peroxide, mupirocin, bacitracin, polymyxin B, neomycin, triclosan, parachlorometaxylene, foscarnet,
  • a personal care product may comprise a neutralizing agent to neutralize carboxyl groups present in one or more other component, such as carboxyl groups in a thickening agent.
  • Suitable neutralizing agents include diisopropylamine and triethanolarnine.
  • the composition may comprise a surfactant.
  • the surfactant may be an anionic surfactant, a cationic surfactant, an ampholytic surfactant, or a nonionic surfactant.
  • nonionic surfactants include polyethoxylates, fatty aicohols (e.g., ceteth-20 (a cetyl ether of polyethylene oxide having an average of about 20 ethylene oxide units) and other "BRIJ®" nonionic surfactants available from ICI Americas, Inc. (Wilmington, DE)), cocamidopropyl betaine, alkyl phenols, fatty acid esters of sorbitol, sorbitan, or polyoxyethylene sorbitan.
  • a specific non-limiting example of a non-ionic surfactant is Glucopon® 215 (Cognis), an aqueous solution of alkyl polyglycosides based on a natural fatty alcohol C8-C10.
  • Suitable anionic surfactants include ammonium lauryl sulfate and lauryl ether sulfosuccinate.
  • a personal care product may comprise water.
  • a compositions used in a personal care product may comprise a hydrogel comprising, for example, a compound such as hydroxypropylmethyl cellulose, cationic hydroxyethyl cellulose (U-care polymers), ethyl cellulose, hydroxypropyl cellulose, hydroxymethyl cellulose, carboxy methyl cellulose, polyethylene oxide (polyox resins), and chitosan pyrrolidone carboxylate (Kytomer PC).
  • a compound such as hydroxypropylmethyl cellulose, cationic hydroxyethyl cellulose (U-care polymers), ethyl cellulose, hydroxypropyl cellulose, hydroxymethyl cellulose, carboxy methyl cellulose, polyethylene oxide (polyox resins), and chitosan pyrrolidone carboxylate (Kytomer PC).
  • a personal care product may comprise an alcohol or a mixture of alcohols, for example, ethanol, isopropyl alcohol, n-propyi alcohol, and mixtures thereof; fatty alcohols, including, but not limited to, cetyl alcohol, myristol alcohol, stearyl alcohol, octyl alcohol, decyl alcohol and lauryl alcohol, and mixtures thereof; and hexanol.
  • alcohols for example, ethanol, isopropyl alcohol, n-propyi alcohol, and mixtures thereof
  • fatty alcohols including, but not limited to, cetyl alcohol, myristol alcohol, stearyl alcohol, octyl alcohol, decyl alcohol and lauryl alcohol, and mixtures thereof
  • hexanol for example, ethanol, isopropyl alcohol, n-propyi alcohol, and mixtures thereof.
  • compositions used in a personal care product may comprise a silicone polymer, for example one or more than one polydiinethylsiloxane polymer (Dow Corning 225 Silicone Fluid), dimethiconol fluid in dimethicone (Dow Corning 1403 Silicone Fluid), cyciomefhicone and dimethicone copolyl (Dow Coming 3225C Silicone Fluid), and silicone glycol (BASF 1 066 DCG polyol).
  • a silicone polymer for example one or more than one polydiinethylsiloxane polymer (Dow Corning 225 Silicone Fluid), dimethiconol fluid in dimethicone (Dow Corning 1403 Silicone Fluid), cyciomefhicone and dimethicone copolyl (Dow Coming 3225C Silicone Fluid), and silicone glycol (BASF 1 066 DCG polyol).
  • a compositions used in a personal care product may comprise an emollient solvent such as a glycidyl ether having an alkyl chain up to and including 18 carbon molecules and ethoxylates and propoxylates thereof, a glyceryl ether having an alkyl chain up to and including 18 carbon molecules and ethoxylates and propoxylates thereof, a mono- or diglyceryl ether having an alkyl chain up to and including 18 carbon molecules and ethoxylates and propoxylates thereof, ethoxylate and propoxylate ethers, ethoxy diglycol esters, ethyl hexyl alcohol propoxylate, and propylene glycol esther ethoxylates and propoxylates, and Arlamol (Alias).
  • an emollient solvent such as a glycidyl ether having an alkyl chain up to and including 18 carbon molecules and ethoxylates and propoxylates thereof, a g
  • a composition used in a personal care product may comprise one or more additive such as a dye, fragrance, pH adjuster, including basic pH adjusters such as ammonia, mono-, di- and tri- alkyl amines, mono-, di- and tri-alkanolamines, alkali metal and alkaline earth metal hydroxides (e.g., ammonia, sodium hydroxide, potassium hydroxide, lithium hydroxide, monoethanolamine, triethylamine, isopropylamine, diethanolamine and triethanolamine); acid pH adjusters such as mineral acids and polycarboxylic acids (e.g., hydrochloric acid, nitric acid, phosphoric acid, sulfuric acid, citric acid, glycolic acid, and lactic acid); a vitamin such as vitamin A, vitamin E and vitamin C; a polyamino acid or salt thereof, ethylenediamine tetraacidic acid (EDTA), a preservative such as Germall plus or DMDM hy
  • basic pH adjusters such
  • a personal care composition has both antimicrobial and anti-inflammatory (AM-AI) activities, and, for example, may be used as a skin cleanser or topical cream.
  • AM-AI antimicrobial and anti-inflammatory
  • the present subject matter also provides for rapidly acting AMI hand disinfectant lotions.
  • GSE Benzyl alcohol
  • 1,3 propanediol when used along with the anti inflammatory agent CRMN, edible plant extract (Kefiprotect®) and Pomegranate seed oil (PSO) exhibits additional antimicrobial activity.
  • the present subject matter provides for the preparation of topical cream formulations containing anti-irritant, anti-inflammatory agents, gelling agents, and botanicals for minor cuts and wounds.
  • Antifungal activity of antifungal agents can be significantly enhanced by the use of a combination of alcohols such as benzyl alcohol, fruit acids, and optionally biguanide and benzalkonium chloride.
  • the present subject matter also provides formulations containing GSE, benzyl alcohol, Zemea®, THC, and a coconut based phospholipid for alcohol-based hand sanitizer (AHS) compositions.
  • the present subject matter also provides for alcohol free botanical hand disinfectant lotions comprising between about 0.5% and 2% (w/w) benzyl alcohol; between about 0.3% and 2% (w/w) silicone fluid; between about 0.1% and 0.5% (w/w) zinc oxide; between about 0.1% and 2% (w/w) fruit acid, for example, lactic acid or citric acid; between about 0.05% and 1% (w/w) of one or more botanical selected from aloe gel, GSE, citrus extract, wasabi extract, willow bark extract, aspen bark extract and honeysuckle extract; and between about 0.1 % and 0.5% (w/w) of one or more essential oil selected from oregano oil, pomegranate oil, rosemary oil, lemongrass oil and cinnamon oil (e.g., cinnamon leaf oil or cinnamon bark oil).
  • Such compositions can optionally comprise between about 0.5% and 2% (w/w) famesol, between about 0.05% and 0.3% (w/w) thymol, and/or between about 0.2% and 1 %
  • Non-limiting examples of alcohol free botanical hand disinfectant lotion, formulations are as follows.
  • Polowax NF 0.5-2.0 Incroquat TMS 0.5-4.0
  • Oregano oil 0.1-0.3 Thymol 0.05-0.3
  • Grapefruit seed/other Citrus extract 0.3-1.0
  • Wasabi extract 0.1-0.5 Benzoic acid 0.2-0.5 Sodium Benzoate 0.2-0.5 Adjust pH to 5.5-6.0
  • a specific non-limiting specific example of an alcohol free botanical hand disinfectant lotion formulation of the present application includes the following formulation.
  • a non- limiting general example of an alcohol free botanical hand disinfectant lotion formulation of the present application includes the following formulation.
  • a specific non-limiting specific example of an alcohol free botanical hand disinfectant lotion formulation of the present application includes the following formulation.
  • Silicone fluid 1.0 Lactic acid 0.2
  • a non-limiting ; genera] example of an alcohol free botanical hand disinfectant lotion formulation of the present application includes the following formulation.
  • Silicone fluid 0.3-1.0 Lactic acid 0.1-2.0
  • a specific non-iimiting specific example of an alcohol free botanical hand disinfectant lotion formulation of the present application includes the following formulation.
  • Silicone fluid 1.0 Lactic acid 0.2
  • the present subject matter also provides for aqueous botanical hand disinfectant lotions containing benzyl alcohol and botanicals.
  • aqueous botanical hand disinfectant lotions containing benzyl alcohol and botanicals A non-limiting general example of such a formulation includes the following.
  • Polowax NF 0.5-2.0 lncroquat TMS 0.5-4.0
  • Plant based alcohol (SD A40B from corn ) 10-20
  • a specific non-limiting specific example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • Aqueous Botanical Hand Disinfectant Lotion A Ingredients % w/w
  • Plant based alcohol SDA40B from corn
  • Pomegranate oil 0.3 Rosemary oil 0.3 Lemongrass oil 0.2 Thymol 0.1
  • a non-limiting general example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • Aqueous Botanicaf Hand Disinfectant Lotion B Ingredients Range (%w/w)
  • a non-limiting specific example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • a non-limiting general example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • Aqueous Botanical Hand Disinfectant Lotion 1 Ingredients _ Range (%w/ )
  • a non-limiting specific example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • a non-limiting general example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • Plant based alcohol SDA40B from corn 10-20 Pomegranate oil 0-1.0 Rosemary oil 0-1.0 Lemongrass oil 0.1-0.5
  • a non-limiting specific example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • Polowax NF 0.5 incroquat TMS 0.5
  • a non-limiting general example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • a non-limiting specific example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • Cinnamon leaf oil 0.1 Bisabolol 0.05
  • Cetrimonium chloride 0.5 Adjust pH to 5.5-6.0
  • the present subject matter also provides for aqueous botanical hand disinfectant foams containing benzyl alcohol and botanicals.
  • a non-limiting general example of such a formulation includes the following.
  • Grapefruit seed extract 0.3-1.0
  • Solubulizer (Peg-40 hydrogenated Castor oil, Trideceih 9, water) 1-3
  • Silicone (silsurf) 0.5-2.0 Adjust pH 4.0-4.5
  • a non-limiting specific example of an aqueous botanical hand disinfectant foam containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • Solubulizer (Peg-40 hydrogenated Castor oil, Trideceth 9, water) 2.0 SDA-40 B (natural) 10
  • Silicone (silsurf) 1.4 Adjust pH 4.0-4.5
  • a non-limiting general example of an aqueous botanical hand disinfectant foam containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • Solubulizer (Peg-40 hydrogenated Castor oil, Trideceth 9, water) 1-3
  • Silicone (silsurf) 0.5-2.0 Adjust pH 4.0-4.5
  • a non-limiting specific example of an aqueous botanical hand disinfectant foam containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • Solubulizer (Peg-40 hydrogenated Castor oil, Trideceth 9, water) 2.0
  • a non-limiting general example of an aqueous botanical hand disinfectant foam containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • Solubulizer (Peg-40 hydrogenated Castor oil, Trideceth 9, water) 1 -3
  • a non-limiting specific example of an aqueous botanical hand disin fectant foam containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • a non-limiting general example of an aqueous botanical hand disinfectant foam containing benzyl alcohol, and botanicals of the present application includes the following formulation.
  • Grapefruit seed extract 0.3-1.0
  • Solubulizer (Peg-40 hydrogenated Castor oil, Trideceth 9, water) 1-3
  • Phospholipid PTM (Croda) 0-1.0 Famesol/Bisabolol 0.3-1.0
  • a non-limiting specific example of an aqueous botanical, hand disinfectant foam containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • Solubulizer (Peg-40 hydrogenated Castor oil, Trideceth 9, water) 2.0
  • Silicone (silsurf) 1 -4 Adjust pH 4.0-4.5
  • a non-limiting general example of an aqueous botanical hand disinfectant foam containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • Soiubulizer (Peg-40 hydrogenated Castor oil, Trideceth 9, water) 1-3
  • Plantasol Caprylyl capryl glucoside
  • Biowax PEG-8 dimethicone
  • Adjust pH 4.0-4.5
  • a non-limiting specific example of an aqueous botanical hand disinfectant foam containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • Solubulizer (Peg-40 hydrogenated Castor oil, Trideceth 9, water) 1.5
  • the present subject matter also provides for natural alcohol foam hand disinfectants containing benzyl alcohol and botanicals.
  • a non-limiting general example of such a formulation includes the following.
  • a non-limiting specific example of a natural alcohol foam hand disinfectant containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • a non-limiting general example of a natural alcohol foam hand disinfectant containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • PEG 10 dimethicone (Ultrapure MFB-10) 0.5-3.0
  • a non-limiting specific example of a natural alcohol foam hand ismfectant containing benzyl alcohol and botanicals of the present application ncludes the following formulation.
  • Phenyl ethanol 1.0 Zemea (1 ,3- Propane diol) 1.0
  • the present subject matter also provides for natural alcohol surgical hand disinfectants containing benzyl alcohol and botanicals.
  • a non-limiting general example of such a formulation includes the following. Natural Alcohol Surgical Hand Disinfectant
  • Sensiva (Ethylhexyl glycerin) 0.05-3.0 Bisaboiol 0.05-0.5
  • a non-limiting specific example of a natural alcohol surgical hand disinfectant containing benzyl alcohol and botanicals of the present application includes the following formulation. Natural Alcohol Surgical Hand Disinfectant ingredients % w/w
  • the present subject matter also provides for botanical disinfectant soaps containing benzyl alcohol and botanicals.
  • a non-limiting general example of such a formulation includes the following.
  • Lemongrass oil 0.05-2.0
  • a non-limiting specific example of a botanical disinfectant soap containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • a non-limiting general example of a botanical disinfectant soap containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • Lemongrass oil 0.05-2.0
  • a non-limitmg specific example of a botanical disinfectant soap containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • a non-limiting general example of a botanical disinfectant soap containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • a non-limiting specific example of a botanical disinfectant soap containing benzyl alcohol and botanicals of the present application includes the following formulation.
  • Botanical Disinfectant Soap ingredients % w/w
  • an anti-fungal, anti-itch composition comprising from about 0.5%(w/w) to about 5% (w/w) benzyl alcohol and one or more compounds selected from the group consisting of :
  • an anti-fungal, anti-itch composition is provided, as follows: Ingredient Ranee (%w/w)
  • Zinc oxide 0.5-2.0
  • a non-limiting general example of an alcohol-free botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application, where a Phase A solution and a Phase B solution are first prepared separately and then mixed, includes the following formulation.
  • Silicone fluid Dimethicone200/350 1-3.0 Aloe juice 0.5-2.0 Bisabolol 0.05-0.2
  • Oregano oil 0.05-0.2
  • a non-limiting specific example of an alcohol-free botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application, where a Phase A solution and. a Phase B solution are first prepared separately and then mixed, includes the following formulation.
  • a non-limiting general example of an alcohol-free botanical hand disinfectant foam of the present application includes the following formulation.
  • Solubulizer (Peg-40 hydrogented 1 -4 Castor oil, Trideceth 9, water)
  • Coco amido propyl betaine 0.5-2.0 Adjust pH 4.0-4.5
  • a non-limiting specific example of an alcohol-free botanical hand disinfectant foam of the present application includes the following formulation.
  • Solubulizer (Peg-40 hydrogented 3.0 Castor oil, Trideceth 9, water)
  • Plantasol Caprylyl capryl glucoside
  • Biowax PEG-8 dimethicone
  • Coco amido propyl betaine Adjust pH- 4.0-4.5
  • compositions of the present subject matter may be used to promote wound healing and/or to inhibit surface infections.
  • the compositions of the present subject matter may be utilized in products such as topical creams and lotions, wound care products, bum wound cream, decubitous ulcer cream (with anti-inflammatory botanicals and the use of silver sulfadiazene as an anti-microbial agent), and therapeutic ointments.
  • the compositions of the present subject matter may also be applied to wound care items, such as, but not limited to, wound healing ointments, wound coverings, burn wound cream, bandages, tape, and steri-strips, and medical articles such as medical gowns, caps, face masks, and shoe-covers, surgical drops, etc.
  • a composition may comprise a thickening and/or gelling agent such as stearyl alcohol, cationic hydroxy ethyl cellulose (Ucare; JR30), hydroxy propyl methyl cellulose, hydroxy propyl cellulose (Klucel), chitosan pyrrolidone carboxylate (Kytamer), behenyl alcohol, zinc stearate, emulsifying waxes, including but not limited to Incroquat and Polawax, an addition polymer of acrylic acid, a resin such as Carbopol® ETDTM 2020, guar gum, acacia, acryiates/stearefh-20 methacrylate copolymer, agar, algin, alginic acid, ammonium acrylate co-polymers, ammonium alginate, ammonium chloride, ammonium sulfate, amylopectin, attapulgite, bentonite, C9-15
  • the gelling agents used in vehicles may be natural gelling agents such as natural gums, starches, pectins, agar and gelatin. Often, the gelling agents are based on polysaccharides or proteins Examples include but are not limited to guar gum, Xanthum gum, Alginic acid (E400), sodium alginate (E401), potassium alginate (E402), ammonium alginate (E403), calcium alginate (E404, - polysaccharides from brown algae), Agar (E406, a polysaccharide obtained from red seaweeds), Carrageenan (E407, a polysaccharide obtained from red seaweeds), Locust bean gum (E410, a natural gum from the seeds of the Carob tree), Pectin (E440, a polysaccharide obtained from apple or citrus-fruit), and Gelatin (E441 , made by partial hydrolysis of animal collagen).
  • guar gum Alginic acid (E400), sodium alginate (
  • Various embodiments may comprise a stabilizer.
  • sodium perborate is used as the stabilizing agent in an amount ranging from about 0.3 to about 1% w w.
  • the application may further comprise a surfactant.
  • the surfactant may be an anionic surfactant, a cationic surfactant, an ampho lytic surfactant, or a nonionic surfactant.
  • nonionic surfactants include polyethoxylates, fatty alcohols (e.g., ceteth-20 (a cetyl ether of polyethylene oxide having an average of about 20 ethylene oxide units) and other "BRIJ®" nonionic surfactants available from iCI Americas, Inc. (Wilmington, Del.)), cocamidopropyl betaine, alkyl phenols, fatty acid esters of sorbitol, sorbitan, or polyoxyethylene sorbitan.
  • Suitable anionic surfactants include ammonium lauryl sulfate and lauryl ether sulfosuccinate.
  • Preferred surfactants include lauroyl ethylenediamine triacetic acid sodium salt, Pkironic F87, Masil SF-19 (BASF) and incromide.
  • Water used in the formulations described herein is preferably deionized water having a neutral pH.
  • the present subject matter provides for a wound healing topical cream containing silver sulfadiazine, an insoluble zinc salt, a soluble zinc salt and calendula oil.
  • the present subject matter provides for a wound healing topical cream containing silver sulfadiazine, an insoluble zinc salt, a soluble zinc salt, calendula oil, and anti inflammatory agents such as a curcumin compound.
  • Non-limiting examples of cream products may further contain white petrolatum (2-20%), fatty alcohol (2-20%), emollient (1-10%), emulsifying agent (0.5-10%o), humectant (2-15%), preservative (0.1-0.5%)), and deionized or distilled water q.s. 100%.
  • Fatty alcohols include stearyl, alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, and other known fatty alcohols.
  • Emollients include isopropyl myristate, lanolin, lanolin derivatives, isopropyl palmitate, isopropyl stearate, emu oil, linseed oil and other known emollients.
  • Emulsifying agents include sodium mono- oleate and polyoxyl 40 stearate.
  • Humectants include propylene glycol, sorbitol, or glycerine or mixture thereof.
  • Suitable water soluble preservatives include parabens, sorbic acid, benzoic acid, diazolidinyl urea, and iodopropylbutylcarbamate (GermaR).
  • the present subject matter provides for botanical wound healing gel formulation comprising benzyl alcohol and botanicals.
  • botanical wound healing gel formulation comprising benzyl alcohol and botanicals.
  • a non-limiting general example of such a formulation includes the following. Botanical Wound Healing Gel

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pest Control & Pesticides (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
PCT/US2012/037135 2011-11-03 2012-05-09 Botanical antimicrobial composition WO2013066403A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CN201280064657.3A CN104039338A (zh) 2011-11-03 2012-05-09 植物性抗微生物组合物
IN4034CHN2014 IN2014CN04034A (enrdf_load_stackoverflow) 2011-11-03 2012-05-09
EP12846062.3A EP2775847A4 (en) 2011-11-03 2012-05-09 BOTANICAL ANTIMICROBIAL COMPOSITION
CA2890395A CA2890395C (en) 2011-11-03 2012-05-09 Botanical antimicrobial compositions
AU2012333187A AU2012333187A1 (en) 2011-11-03 2012-05-09 Botanical antimicrobial composition
JP2014539926A JP2015501330A (ja) 2011-11-03 2012-05-09 抗菌性組成物、治癒組成物、洗浄組成物、抗カビ性局所用クリーム、食用消毒クレンザー、表面消毒剤、殺虫剤
US14/267,606 US9968101B2 (en) 2011-11-03 2014-05-01 Botanical antimicrobial compositions
US15/928,735 US20180206505A1 (en) 2011-11-03 2018-03-22 Botanical Antimicrobial Compositions

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US201161555367P 2011-11-03 2011-11-03
US61/555,367 2011-11-03
US201161567372P 2011-12-06 2011-12-06
US61/567,372 2011-12-06
US201261583505P 2012-01-05 2012-01-05
US201261583482P 2012-01-05 2012-01-05
US61/583,505 2012-01-05
US61/583,482 2012-01-05
US201261583998P 2012-01-06 2012-01-06
US61/583,998 2012-01-06
US13/412,464 US20130230609A1 (en) 2012-03-05 2012-03-05 Antimicrobial/preservative compositions comprising botanicals
US13/412,464 2012-03-05

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/412,464 Continuation-In-Part US20130230609A1 (en) 2011-11-03 2012-03-05 Antimicrobial/preservative compositions comprising botanicals

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/267,606 Continuation US9968101B2 (en) 2011-11-03 2014-05-01 Botanical antimicrobial compositions

Publications (1)

Publication Number Publication Date
WO2013066403A1 true WO2013066403A1 (en) 2013-05-10

Family

ID=48192554

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/037135 WO2013066403A1 (en) 2011-11-03 2012-05-09 Botanical antimicrobial composition

Country Status (7)

Country Link
EP (1) EP2775847A4 (enrdf_load_stackoverflow)
JP (1) JP2015501330A (enrdf_load_stackoverflow)
CN (1) CN104039338A (enrdf_load_stackoverflow)
AU (1) AU2012333187A1 (enrdf_load_stackoverflow)
CA (1) CA2890395C (enrdf_load_stackoverflow)
IN (1) IN2014CN04034A (enrdf_load_stackoverflow)
WO (1) WO2013066403A1 (enrdf_load_stackoverflow)

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014203263A1 (en) * 2013-06-18 2014-12-24 Colgate-Palmolive Company Antimicrobial compositions comprising essential oil combinations
CN104306212A (zh) * 2014-09-29 2015-01-28 青岛康合伟业商贸有限公司 一种可促进伤口愈合的洗面奶
WO2016036341A1 (en) * 2014-09-01 2016-03-10 Colgate-Palmolive Company Zinc-containing compositions with essential oils
WO2016065609A1 (en) * 2014-10-31 2016-05-06 Kimberly-Clark Worldwide, Inc. Anti-adherent botanical compositions
WO2016123308A1 (en) * 2015-01-28 2016-08-04 Lonza, Inc. Preservative compositions for formulations
CN106232091A (zh) * 2014-02-14 2016-12-14 凯敏工业公司 牛至油及辛酸混合物的抗菌作用
EP2970834A4 (en) * 2013-03-15 2017-05-10 The Trustees of Columbia University in the City of New York Broad spectrum natural preservative composition
WO2017087559A1 (en) 2014-11-18 2017-05-26 Gore Jessica Adelle Natural edible cleaning composition
KR101748152B1 (ko) 2015-03-04 2017-06-19 대한민국 참나무시들음병균의 생장을 억제하기 위한 항균제 조성물 및 이를 포함하는 천연 항균제
US9687429B2 (en) 2007-06-20 2017-06-27 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing low concentrations of botanicals
WO2018022016A1 (en) * 2016-07-26 2018-02-01 Colgate-Palmolive Company Liquid cleansing compositions with an antibacterial system and method of manufacturing thereof
US9968101B2 (en) 2011-11-03 2018-05-15 The Trustees Of Columbia University In The City Of New York Botanical antimicrobial compositions
US9969885B2 (en) 2014-07-31 2018-05-15 Kimberly-Clark Worldwide, Inc. Anti-adherent composition
US9981069B2 (en) 2007-06-20 2018-05-29 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US10028899B2 (en) 2014-07-31 2018-07-24 Kimberly-Clark Worldwide, Inc. Anti-adherent alcohol-based composition
WO2019023685A1 (en) * 2017-07-27 2019-01-31 The Trustees Of Columbia University In The City Of New York POLYMERIC FILMS WITH ANTIMICROBIAL AGENTS
WO2019055925A1 (en) * 2017-09-15 2019-03-21 Gojo Industries, Inc. ANTIMICROBIAL COMPOSITION
US10238107B2 (en) 2014-07-31 2019-03-26 Kimberly-Clark Worldwide, Inc. Anti-adherent composition
US10271551B2 (en) 2016-06-22 2019-04-30 Lonza Inc. Preservative composition for wet wipes
RU2691479C1 (ru) * 2018-07-31 2019-06-14 Общество с ограниченной ответственностью Научно-Технический Центр "Химинвест" Способ переработки осиновой коры
WO2019180041A1 (en) * 2018-03-19 2019-09-26 Livinguard Ag Organic disinfecting agent
US10542760B2 (en) 2007-06-20 2020-01-28 The Trustees Of Columbia University In The City Of New York Skin and surface disinfectant compositions containing botanicals
JP2020509080A (ja) * 2017-01-31 2020-03-26 クラソリューションズ ゲーエムベーハーＣｕｒａｓｏｌｕｔｉｏｎｓ Ｇｍｂｈ バイオフィルムの抗菌処理のための作用増強抗菌組成物
WO2020094864A1 (en) * 2018-11-09 2020-05-14 Mother Earth Dermatics (Med) Gmbh Insect repellent composition
EP3554233A4 (en) * 2016-12-16 2020-07-22 Vertellus Holdings LLC QUATERNARY AMINE FORMULATIONS AND THEIR USES
WO2020165566A1 (en) * 2019-02-11 2020-08-20 Reckitt Benckiser Health Limited Topical sanitizing compositions
EP3706575A1 (en) * 2017-11-06 2020-09-16 Clean Nature Solutions GmbH Synergistic composition for universal increase of agricultural production
RU2733718C1 (ru) * 2020-01-20 2020-10-06 ООО "Фитолон-Наука" Композиция в форме геля для ухода за тканями полости рта
US10806144B2 (en) 2011-11-03 2020-10-20 The Trustees Of Columbia University In The City Of New York Composition with sustained antimicrobial activity
US11168287B2 (en) 2016-05-26 2021-11-09 Kimberly-Clark Worldwide, Inc. Anti-adherent compositions and methods of inhibiting the adherence of microbes to a surface
US11319512B2 (en) 2014-11-18 2022-05-03 Jessica Adelle Gore Natural edible cleaning composition
US20220401506A1 (en) * 2021-01-13 2022-12-22 The Tao Talit Corporation Organic pain relief and hair growth composition
WO2023111093A1 (en) * 2021-12-15 2023-06-22 Purac Biochem B.V. Concentrates and preservative compositions prepared therefrom
US11737458B2 (en) 2015-04-01 2023-08-29 Kimberly-Clark Worldwide, Inc. Fibrous substrate for capture of gram negative bacteria
CN118059014A (zh) * 2024-04-19 2024-05-24 广州汇芬生物科技有限公司 一种宠物皮肤用抑菌剂及其制备方法
US12037497B2 (en) 2016-01-28 2024-07-16 Kimberly-Clark Worldwide, Inc. Anti-adherent composition against DNA viruses and method of inhibiting the adherence of DNA viruses to a surface
RU2827882C1 (ru) * 2023-12-21 2024-10-03 Сергей Владимирович Сирак Ранозаживляющий гель для лечения хейлитов и хронических трещин губ у пациентов с ортодонтической патологией

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104371826A (zh) * 2014-10-31 2015-02-25 湖北中烟工业有限责任公司 一种具有防腐作用的天然烟用辛香香料
CN104818140A (zh) * 2015-04-30 2015-08-05 威莱(广州)日用品有限公司 一种抗菌洗洁精
JP2017066071A (ja) * 2015-09-29 2017-04-06 株式会社マンダム 化粧料組成物
MY191276A (en) * 2016-10-09 2022-06-13 Shenzhen Eulikan Biotechnology Co Ltd Use of antimicrobial agent combination in preparing composition for vagina, composition for vagina and method for preparing the same
CN106719948A (zh) * 2016-11-29 2017-05-31 福建味道生物科技有限公司 一种生物农药的制备方法
CN106719947A (zh) * 2016-11-29 2017-05-31 福建味道生物科技有限公司 一种环保生物农药配方
CN108186618B (zh) * 2017-08-02 2021-03-02 成都医学院 柠檬醛及其衍生物在制备mrsa感染性疾病药物中的新用途
CN107647974A (zh) * 2017-10-20 2018-02-02 福建恒安卫生材料有限公司 功能性复合芯体的制备方法
CN107875087A (zh) * 2017-11-17 2018-04-06 东兴市良佳优农林科技有限公司 保湿滋润型除菌洗手液及其制备方法
CN107875088A (zh) * 2017-11-17 2018-04-06 东兴市良佳优农林科技有限公司 除菌洗手液及其制备方法
CN107951808A (zh) * 2017-12-24 2018-04-24 姚佑灿 一种清洁杀菌的组合物
JP6454805B1 (ja) * 2018-03-26 2019-01-16 株式会社Adeka アルコール製剤及びそれを用いた消毒方法
RU2704038C1 (ru) * 2018-04-25 2019-10-23 Светлана Александровна Чубатова Базовая композиция для приготовления биологически активного средства обработки среды обитания человека
EP3824896A4 (en) * 2018-07-20 2022-08-24 Shiseido Company, Ltd. VIRUS INACTIVATION AGENT
CN113473858B (zh) * 2019-02-26 2024-12-03 大日本除虫菊株式会社 杀菌或病毒灭活剂组合物和杀菌或病毒灭活效力增强方法
CN117562085A (zh) * 2019-02-26 2024-02-20 大日本除虫菊株式会社 杀菌或病毒灭活剂组合物和杀菌或病毒灭活效力增强方法
CN109646361B (zh) * 2019-02-27 2022-03-29 山东信得科技股份有限公司 一种宠物用复合型生物除臭喷剂及其制备方法
JP7560948B2 (ja) * 2020-03-17 2024-10-03 大日本除蟲菊株式会社 殺菌剤組成物および殺菌効力増強方法
CN111733597B (zh) * 2020-06-02 2023-05-02 苏州工业园区安诺科斯化妆品研发有限公司 一种口罩除臭剂及其制备方法
CN111803696B (zh) * 2020-07-10 2022-02-18 中山大学 一种用于皮肤创伤修复的广藿香油纳米复合膜的制备方法
JPWO2022019319A1 (enrdf_load_stackoverflow) * 2020-07-21 2022-01-27
KR102492710B1 (ko) * 2020-11-05 2023-01-26 송운서 일회용 항균면봉 및 이의 제조방법
US12029809B2 (en) * 2021-06-10 2024-07-09 Pauleine Prospere Hair or skin treatment composition and methods of preparation and use
CN113598354A (zh) * 2021-08-11 2021-11-05 广元九道梁食品有限公司 一种魔芋素毛肚及其制备方法
CN113712051A (zh) * 2021-10-20 2021-11-30 台州诺洁日用品有限公司 植物抑菌剂组合物及其应用
CN115844755B (zh) * 2022-12-27 2024-08-20 媞颂日化用品(广州)有限公司 一种宠物用祛泪痕凝胶及其制备方法和应用
CN118697680B (zh) * 2024-08-05 2025-07-25 广东华妍生物科技有限公司 含多种植物提取物的抑菌组合物及其应用

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891422A (en) * 1996-10-10 1999-04-06 Warner-Lambert Company Antimicrobial composition containing a C3 -C6 alcohol
US20020192256A1 (en) * 2000-09-06 2002-12-19 Chang-An Wu Water miscible pesticide containing a synergistic cocktail of plant alkaloids
US6537955B1 (en) * 1997-10-14 2003-03-25 The Procter & Gamble Company Cleaning and disinfecting compositions comprising C6- C7 alkyl sulfate
US20030213168A1 (en) * 2002-04-01 2003-11-20 Anthony Hesse Compositions, methods and devices for enhancing landscaping materials
US20060233901A1 (en) * 2005-04-01 2006-10-19 Jamieson Gene C Oils of capsaicinoids and methods of making and using the same
US20070014823A1 (en) * 2005-07-12 2007-01-18 The Procter & Gamble Company Multi phase personal care composition comprising compositions having similar rheology profile in different phases
US20070190094A1 (en) * 2006-01-10 2007-08-16 Ecosmart Technologies, Inc. Pesticidal compositions containing isopropyl-containing compounds as pesticidally active ingredients
US20080063607A1 (en) * 2003-08-04 2008-03-13 Foamix Ltd Oleaginous pharmaceutical and cosmetic foam
US20080253976A1 (en) * 2007-04-16 2008-10-16 Douglas Craig Scott Personal Care Compositions Comprising An Antimicrobial Blend of Essential Oils or Constituents Thereof
US20080318784A1 (en) * 2007-06-22 2008-12-25 Moghu Research Center Ltd. Use of 5-benzyloxymethyl-1,2-isoxazoline derivatives as a herbicide
US20090191288A1 (en) * 1996-02-12 2009-07-30 Squires Meryl J Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases
US20100172847A1 (en) * 2007-06-20 2010-07-08 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing low concentrations of botanicals
US20100248962A1 (en) * 2009-03-31 2010-09-30 Smg Brands, Inc. Compositions for the masking of malodor in agricultural compositions and methods of making and using thereof
WO2011002929A1 (en) * 2009-06-30 2011-01-06 The Trustees Of Columbia University In The City Of New York Antimicrobial/preservative compositions comprising botanicals

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073366A (en) * 1989-05-30 1991-12-17 Fred Beck Analgesic composition useful in providing a temporary relief from symptoms of arthritis
US5135747A (en) * 1991-05-17 1992-08-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Deodorant/antiperspirant products with fragrance and encapsulated odor counteractant
JPH09323910A (ja) * 1996-06-03 1997-12-16 Baasu Kk 水質・土質改良作用を併有する殺藻剤
US6348501B1 (en) * 1999-09-29 2002-02-19 Medical Merchandising, Inc. Lotion compositions utilizing capsaicin
EP1283673A2 (en) * 2000-05-26 2003-02-19 The Procter & Gamble Company Soap based pesticides
JP2002193717A (ja) * 2000-12-28 2002-07-10 Okada Giken:Kk 抗菌剤
US20030113388A1 (en) * 2001-12-13 2003-06-19 Dung Phan Methods of treatment for skin disorders using turmeric extract and a hydroxy acid
JP4687874B2 (ja) * 2005-02-16 2011-05-25 日本曹達株式会社 徐放性ゲル組成物
US20080166314A1 (en) * 2005-11-01 2008-07-10 Juice Beauty Compositions for juice-based treatment serums
JP5025985B2 (ja) * 2006-04-27 2012-09-12 株式会社Ａｄｅｋａ 抗菌剤及びこれを含有する抗菌性組成物
JP5398292B2 (ja) * 2009-02-10 2014-01-29 ライオン株式会社 液体洗浄剤組成物
JP2010083806A (ja) * 2008-09-30 2010-04-15 Kobayashi Pharmaceut Co Ltd 蓄圧式スプレー容器に収容された除菌用製品

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090191288A1 (en) * 1996-02-12 2009-07-30 Squires Meryl J Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases
US5891422A (en) * 1996-10-10 1999-04-06 Warner-Lambert Company Antimicrobial composition containing a C3 -C6 alcohol
US6537955B1 (en) * 1997-10-14 2003-03-25 The Procter & Gamble Company Cleaning and disinfecting compositions comprising C6- C7 alkyl sulfate
US20020192256A1 (en) * 2000-09-06 2002-12-19 Chang-An Wu Water miscible pesticide containing a synergistic cocktail of plant alkaloids
US20030213168A1 (en) * 2002-04-01 2003-11-20 Anthony Hesse Compositions, methods and devices for enhancing landscaping materials
US20080063607A1 (en) * 2003-08-04 2008-03-13 Foamix Ltd Oleaginous pharmaceutical and cosmetic foam
US20060233901A1 (en) * 2005-04-01 2006-10-19 Jamieson Gene C Oils of capsaicinoids and methods of making and using the same
US20070014823A1 (en) * 2005-07-12 2007-01-18 The Procter & Gamble Company Multi phase personal care composition comprising compositions having similar rheology profile in different phases
US20070190094A1 (en) * 2006-01-10 2007-08-16 Ecosmart Technologies, Inc. Pesticidal compositions containing isopropyl-containing compounds as pesticidally active ingredients
US20080253976A1 (en) * 2007-04-16 2008-10-16 Douglas Craig Scott Personal Care Compositions Comprising An Antimicrobial Blend of Essential Oils or Constituents Thereof
US20100172847A1 (en) * 2007-06-20 2010-07-08 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing low concentrations of botanicals
US20080318784A1 (en) * 2007-06-22 2008-12-25 Moghu Research Center Ltd. Use of 5-benzyloxymethyl-1,2-isoxazoline derivatives as a herbicide
US20100248962A1 (en) * 2009-03-31 2010-09-30 Smg Brands, Inc. Compositions for the masking of malodor in agricultural compositions and methods of making and using thereof
WO2011002929A1 (en) * 2009-06-30 2011-01-06 The Trustees Of Columbia University In The City Of New York Antimicrobial/preservative compositions comprising botanicals

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2775847A4 *

Cited By (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10542760B2 (en) 2007-06-20 2020-01-28 The Trustees Of Columbia University In The City Of New York Skin and surface disinfectant compositions containing botanicals
US9981069B2 (en) 2007-06-20 2018-05-29 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US9687429B2 (en) 2007-06-20 2017-06-27 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing low concentrations of botanicals
US10806144B2 (en) 2011-11-03 2020-10-20 The Trustees Of Columbia University In The City Of New York Composition with sustained antimicrobial activity
US9968101B2 (en) 2011-11-03 2018-05-15 The Trustees Of Columbia University In The City Of New York Botanical antimicrobial compositions
EP2970834A4 (en) * 2013-03-15 2017-05-10 The Trustees of Columbia University in the City of New York Broad spectrum natural preservative composition
WO2014203263A1 (en) * 2013-06-18 2014-12-24 Colgate-Palmolive Company Antimicrobial compositions comprising essential oil combinations
AU2013392911B2 (en) * 2013-06-18 2016-12-01 Colgate-Palmolive Company Antimicrobial compositions comprising essential oil combinations
US9655838B2 (en) 2013-06-18 2017-05-23 Colgate-Palmolive Company Antimicrobial compositions comprising essential oil combinations
CN106232091A (zh) * 2014-02-14 2016-12-14 凯敏工业公司 牛至油及辛酸混合物的抗菌作用
US9969885B2 (en) 2014-07-31 2018-05-15 Kimberly-Clark Worldwide, Inc. Anti-adherent composition
US10292916B2 (en) 2014-07-31 2019-05-21 Kimberly-Clark Worldwide, Inc. Anti-adherent alcohol-based composition
US10238107B2 (en) 2014-07-31 2019-03-26 Kimberly-Clark Worldwide, Inc. Anti-adherent composition
US10028899B2 (en) 2014-07-31 2018-07-24 Kimberly-Clark Worldwide, Inc. Anti-adherent alcohol-based composition
WO2016036341A1 (en) * 2014-09-01 2016-03-10 Colgate-Palmolive Company Zinc-containing compositions with essential oils
AU2014405603B2 (en) * 2014-09-01 2018-03-29 Colgate-Palmolive Company Zinc-containing compositions with essential oils
CN104306212A (zh) * 2014-09-29 2015-01-28 青岛康合伟业商贸有限公司 一种可促进伤口愈合的洗面奶
US20170367350A1 (en) * 2014-10-31 2017-12-28 Kimberly-Clark Worldwide, Inc. Anti-adherent botanical compositions
KR102291294B1 (ko) * 2014-10-31 2021-08-20 킴벌리-클라크 월드와이드, 인크. 유착 방지 식물성 조성물
WO2016065609A1 (en) * 2014-10-31 2016-05-06 Kimberly-Clark Worldwide, Inc. Anti-adherent botanical compositions
GB2547153B (en) * 2014-10-31 2020-08-05 Kimberly Clark Co Anti-adherent botanical compositions
AU2014409811B2 (en) * 2014-10-31 2021-02-18 Kimberly-Clark Worldwide, Inc. Anti-adherent botanical compositions
GB2547153A (en) * 2014-10-31 2017-08-09 Kimberly Clark Co Anti-adherent botanical compositions
KR20170077132A (ko) * 2014-10-31 2017-07-05 킴벌리-클라크 월드와이드, 인크. 유착 방지 식물성 조성물
US10435653B1 (en) 2014-11-18 2019-10-08 Jessica Adelle Gore Natural edible cleaning composition
EP3377601A4 (en) * 2014-11-18 2019-03-27 Gore, Jessica Adelle NATURAL EDIBLE CLEANING COMPOSITION
WO2017087559A1 (en) 2014-11-18 2017-05-26 Gore Jessica Adelle Natural edible cleaning composition
US11319512B2 (en) 2014-11-18 2022-05-03 Jessica Adelle Gore Natural edible cleaning composition
US11207253B2 (en) 2015-01-28 2021-12-28 Arxada, LLC Preservative compositions for formulations
WO2016123308A1 (en) * 2015-01-28 2016-08-04 Lonza, Inc. Preservative compositions for formulations
KR101748152B1 (ko) 2015-03-04 2017-06-19 대한민국 참나무시들음병균의 생장을 억제하기 위한 항균제 조성물 및 이를 포함하는 천연 항균제
US11737458B2 (en) 2015-04-01 2023-08-29 Kimberly-Clark Worldwide, Inc. Fibrous substrate for capture of gram negative bacteria
US12037497B2 (en) 2016-01-28 2024-07-16 Kimberly-Clark Worldwide, Inc. Anti-adherent composition against DNA viruses and method of inhibiting the adherence of DNA viruses to a surface
US11168287B2 (en) 2016-05-26 2021-11-09 Kimberly-Clark Worldwide, Inc. Anti-adherent compositions and methods of inhibiting the adherence of microbes to a surface
US11089782B2 (en) 2016-06-22 2021-08-17 Lonza, Llc Preservative composition for wet wipes
US10271551B2 (en) 2016-06-22 2019-04-30 Lonza Inc. Preservative composition for wet wipes
AU2016416435B2 (en) * 2016-07-26 2019-10-03 Colgate-Palmolive Company Liquid cleansing compositions with an antibacterial system and method of manufacturing thereof
WO2018022016A1 (en) * 2016-07-26 2018-02-01 Colgate-Palmolive Company Liquid cleansing compositions with an antibacterial system and method of manufacturing thereof
US11104868B2 (en) 2016-07-26 2021-08-31 Colgate-Palmolive Company Liquid cleansing compositions with an antibacterial system and method of manufacturing thereof
EP3554233A4 (en) * 2016-12-16 2020-07-22 Vertellus Holdings LLC QUATERNARY AMINE FORMULATIONS AND THEIR USES
US11825842B2 (en) 2016-12-16 2023-11-28 Aurorium Holdings Llc Quaternary amine formulations and uses thereof
JP7041173B2 (ja) 2017-01-31 2022-03-23 クラソリューションズ ゲーエムベーハー バイオフィルムの抗菌処理のための作用増強抗菌組成物
JP2020509080A (ja) * 2017-01-31 2020-03-26 クラソリューションズ ゲーエムベーハーＣｕｒａｓｏｌｕｔｉｏｎｓ Ｇｍｂｈ バイオフィルムの抗菌処理のための作用増強抗菌組成物
WO2019023685A1 (en) * 2017-07-27 2019-01-31 The Trustees Of Columbia University In The City Of New York POLYMERIC FILMS WITH ANTIMICROBIAL AGENTS
US11678662B2 (en) 2017-09-15 2023-06-20 Gojo Industries, Inc. Antimicrobial composition
CN111093370A (zh) * 2017-09-15 2020-05-01 高乔工业股份有限公司 抗微生物组合物
WO2019055925A1 (en) * 2017-09-15 2019-03-21 Gojo Industries, Inc. ANTIMICROBIAL COMPOSITION
EP3706575A1 (en) * 2017-11-06 2020-09-16 Clean Nature Solutions GmbH Synergistic composition for universal increase of agricultural production
WO2019180041A1 (en) * 2018-03-19 2019-09-26 Livinguard Ag Organic disinfecting agent
RU2691479C1 (ru) * 2018-07-31 2019-06-14 Общество с ограниченной ответственностью Научно-Технический Центр "Химинвест" Способ переработки осиновой коры
EP3876719A1 (en) * 2018-11-09 2021-09-15 Mother Earth Dermatics (MED) GmbH Insect repellent composition
WO2020094864A1 (en) * 2018-11-09 2020-05-14 Mother Earth Dermatics (Med) Gmbh Insect repellent composition
WO2020165566A1 (en) * 2019-02-11 2020-08-20 Reckitt Benckiser Health Limited Topical sanitizing compositions
CN113423469A (zh) * 2019-02-11 2021-09-21 雷克特本克斯尔健康有限公司 局部消毒组合物
AU2020220554B2 (en) * 2019-02-11 2025-02-27 Reckitt Benckiser Health Limited Topical sanitizing compositions
RU2733718C1 (ru) * 2020-01-20 2020-10-06 ООО "Фитолон-Наука" Композиция в форме геля для ухода за тканями полости рта
US20220401506A1 (en) * 2021-01-13 2022-12-22 The Tao Talit Corporation Organic pain relief and hair growth composition
US12383593B2 (en) * 2021-01-13 2025-08-12 The Tao Talit Corporation Organic pain relief and hair growth composition
WO2023111093A1 (en) * 2021-12-15 2023-06-22 Purac Biochem B.V. Concentrates and preservative compositions prepared therefrom
US12408663B2 (en) 2023-04-27 2025-09-09 Gojo Industries, Inc. Antimicrobial composition
RU2827882C1 (ru) * 2023-12-21 2024-10-03 Сергей Владимирович Сирак Ранозаживляющий гель для лечения хейлитов и хронических трещин губ у пациентов с ортодонтической патологией
CN118059014A (zh) * 2024-04-19 2024-05-24 广州汇芬生物科技有限公司 一种宠物皮肤用抑菌剂及其制备方法

Also Published As

Publication number Publication date
CN104039338A (zh) 2014-09-10
EP2775847A4 (en) 2016-01-13
JP2015501330A (ja) 2015-01-15
AU2012333187A1 (en) 2014-06-26
CA2890395A1 (en) 2013-05-10
IN2014CN04034A (enrdf_load_stackoverflow) 2015-10-23
CA2890395C (en) 2021-03-16
EP2775847A1 (en) 2014-09-17

Similar Documents

Publication Publication Date Title
US9968101B2 (en) Botanical antimicrobial compositions
CA2890395C (en) Botanical antimicrobial compositions
AU2010266325B2 (en) Antimicrobial/preservative compositions comprising botanicals
US10542760B2 (en) Skin and surface disinfectant compositions containing botanicals
US9687429B2 (en) Antimicrobial compositions containing low concentrations of botanicals
US20130230609A1 (en) Antimicrobial/preservative compositions comprising botanicals
US20090175806A1 (en) Antimicrobial Compositions Containing Low Concentrations of Botanicals
US20100172848A1 (en) Skin and surface disinfectant compositions containing botanicals
EP2207539A1 (en) Skin and surface disinfectant compositions containing botanicals
AU2019200786B2 (en) Antimicrobial/preservative compositions comprising botanicals
WO2010091415A1 (en) Antimicrobial compositions containing low concentrations of botanicals
CA2464468C (en) Gentle-acting skin-disinfectants and hydroalcoholic gel formulations
US20160000094A1 (en) Broad spectrum natural preservative composition
US20150265666A1 (en) Botanical antimicrobial compositions
US9497975B2 (en) Broad spectrum natural preservative composition
EP2970834A2 (en) Broad spectrum natural preservative composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12846062

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2014539926

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2012846062

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2012333187

Country of ref document: AU

Date of ref document: 20120509

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2890395

Country of ref document: CA